Jazz Pharmaceuticals plc (JAZZ) › RevenueJazz Pharmaceuticals plc (JAZZ) — RevenueAnnual figures by period end, from SEC filings.2016-12-31: $1.49B2017-12-31: $1.62B2018-12-31: $1.89B2019-12-31: $2.16B2020-12-31: $2.36B2021-12-31: $3.09B2022-12-31: $3.66B2023-12-31: $3.83B2024-12-31: $4.07B2025-12-31: $4.27B$4.27B2016-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$4.27B+4.9%2026-02-24From 2025-01-012024-12-31$4.07B+6.1%2026-02-24From 2024-01-012023-12-31$3.83B+4.8%2026-02-24From 2023-01-012022-12-31$3.66B+18.3%2025-02-26From 2022-01-012021-12-31$3.09B+30.9%2024-02-28From 2021-01-012020-12-31$2.36B+9.3%2023-03-01From 2020-01-012019-12-31$2.16B+14.3%2022-03-01From 2019-01-012018-12-31$1.89B+16.8%2021-02-23From 2018-01-012017-12-31$1.62B+8.8%2020-02-25From 2017-01-012016-12-31$1.49B—2019-02-26From 2016-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)